Our cell-free DNA (cfDNA) methylation sequencing platform offers high-sensitivity, high-resolution profiling designed specifically for oncology, prenatal testing, and organ transplant monitoring research. Because cfDNA is highly fragmented and low-abundance, selecting the right methodology is critical — we guide you through whole-genome, enzymatic, and affinity-based options to match your sample and research goals.

• Three sequencing workflows: WGBS, EM-Seq, and MeDIP-Seq
• Low-input EM-Seq supports as little as 1–5 ng cfDNA
• Strict fragment-size QC prevents gDNA contamination
• Bismark-driven pipeline with DMR, deconvolution & fragmentomics